Skip to content
Brand AI

Cocrystal Pharma

Request correction

Corporate brand

UnclaimedRead 2× by AI crawlers

A clinical-stage biotechnology company developing novel antiviral therapeutics.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel broad-spectrum antiviral therapeutics that target the replication process of influenza virus, coronaviruses (including SARS-CoV-2 and MERS), norovirus, and hepatitis C virus.

History

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel broad-spectrum antiviral therapeutics that target the replication process of influenza virus, coronaviruses (including SARS-CoV-2 and MERS), norovirus, and hepatitis C virus.

Recent events

  • Reported

    Cocrystal Pharma licenses K-State coronavirus research[5]

    Cocrystal Pharma entered a new agreement granting it use of two patented series of protease inhibitors developed through K-State research, for further development of a possible COVID-19 treatment.

Read more

Sources5 sources

  1. 1Cocrystal Pharma, Inc. (COCP)cocrystalpharma.com
  2. 2Overview :: Cocrystal Pharma, Inc. (COCP)cocrystalpharma.com
  3. 3Careers :: Cocrystal Pharma, Inc. (COCP)cocrystalpharma.com
  4. 4Cocrystal Pharmawikidata.org
  5. 5Cocrystal Pharma 获得堪萨斯州立大学冠状病毒研究许可cjonline.com

Cite this profile: Cite the canonical profile. /brand-wiki/cocrystal-pharma · Editorial policy · How profiles are compiled